Cargando…
Understanding and meeting injection device needs in multiple sclerosis: a survey of patient attitudes and practices
BACKGROUND: All established disease-modifying drugs for multiple sclerosis require parenteral administration, which can cause difficulties for some patients, sometimes leading to suboptimal adherence. A new electronic autoinjection device has been designed to address these issues. METHODS: Patients...
Autores principales: | Verdun di Cantogno, Elisabetta, Russell, Susan, Snow, Tom |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090378/ https://www.ncbi.nlm.nih.gov/pubmed/21573048 http://dx.doi.org/10.2147/PPA.S14903 |
Ejemplares similares
-
Autoinjector preference in multiple sclerosis and the role of nurses in treatment decisions: results from an international survey in Europe and the USA
por: Verdun di Cantogno, Elisabetta, et al.
Publicado: (2014) -
A systematic review of relapse rates during pregnancy and postpartum
in patients with relapsing multiple sclerosis
por: Hellwig, Kerstin, et al.
Publicado: (2021) -
Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study
por: Devonshire, Virginia, et al.
Publicado: (2010) -
Understanding and meeting the needs of those using growth hormone injection devices
por: Dumas, Hervé, et al.
Publicado: (2006) -
Prognostic factors for long-term outcomes in relapsing–remitting multiple sclerosis
por: Traboulsee, Anthony L, et al.
Publicado: (2016)